Digestives & Intestinal Remedies - Singapore

  • Singapore
  • In Singapore, the Digestives & Intestinal Remedies market market generated a revenue of US$173.10m in 2024.
  • It is projected to experience an annual growth rate of 3.26% (CAGR 2024-2029).
  • When compared globally, in China leads the market with a revenue of US$4,408.00m in 2024.
  • On a per capita basis, each person in Singapore generated a revenue of US$28.59 in 2024.
  • Digestives & Intestinal Remedies in the OTC Pharmaceuticals market in Singapore are experiencing a surge in demand due to the country's growing aging population and increasing prevalence of digestive disorders.

Key regions: Brazil, India, United Kingdom, Germany, China

Region comparison

Analyst Opinion

The Digestives & Intestinal Remedies market in Singapore has been experiencing steady growth in recent years.

Customer preferences:
Customers in Singapore have shown a growing interest in digestive health and are increasingly seeking remedies for digestive issues. This can be attributed to several factors, including changes in dietary habits, increased stress levels, and a greater awareness of the importance of gut health. As a result, there is a high demand for products that help alleviate digestive discomfort and promote overall gut health.

Trends in the market:
One major trend in the Digestives & Intestinal Remedies market in Singapore is the rise in popularity of natural and herbal remedies. Consumers are becoming more conscious of the ingredients in the products they consume and are opting for natural alternatives to traditional pharmaceuticals. This trend is driven by a desire for healthier and more sustainable options, as well as a belief in the efficacy of natural remedies.Another trend in the market is the growing availability of digestive health products in various formats. In addition to traditional pills and tablets, consumers can now choose from a wide range of options such as chewable tablets, powders, and liquid formulations. This allows for greater convenience and customization, catering to different consumer preferences and lifestyles.

Local special circumstances:
Singapore has a highly developed healthcare system and a strong emphasis on preventive healthcare. The government actively promotes healthy living and encourages its citizens to take proactive steps to maintain their well-being. This focus on preventive healthcare has contributed to the growing demand for digestive health products, as consumers are increasingly taking charge of their own health and seeking ways to prevent digestive issues.

Underlying macroeconomic factors:
Singapore has a high standard of living and a well-educated population, which has led to a greater awareness and prioritization of health and wellness. The country's strong economy and high disposable income levels also contribute to the growth of the Digestives & Intestinal Remedies market, as consumers are willing to invest in products that improve their overall well-being.In conclusion, the Digestives & Intestinal Remedies market in Singapore is experiencing growth due to increasing customer preferences for natural and herbal remedies, the availability of a wide range of product formats, local special circumstances that prioritize preventive healthcare, and the underlying macroeconomic factors of Singapore's high standard of living and disposable income levels.


Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.


In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.


  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait


Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)